CETN2 and colorectal carcinoma: Specifically, both CRC cell lines showed an increase (up to approximately 50%) in the proportion of enlarged Centrin-2/3 spots after hormone treatment, which was significantly higher compared to the DMSO control (Supplementary Fig. 3c).